Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

1.21
Delayed Data
As of 9:43am ET
 +0.0125 / +1.04%
Today’s Change
1.15
Today|||52-Week Range
5.70
-30.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Operating ActivitiesNet Income / Starting Line-24.6M-69.1M-30.5M-20.8M
 
 
 
 
 
Depreciation2.0M2.1M2.1M2.1M
 
 
 
 
 
Total Other Cash Flow-10.8M14.8M-7.3M1.7M
 
 
 
 
 
Funds From Operations-33.4M-52.2M-35.7M-17.0M
 
 
 
 
 
Funds From/For Other Operating Expenses323.0K-2.2M4.4M-722.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-33.7M-49.9M-40.1M-16.3M
 
 
 
 
 
 
InvestingIncrease In Investments75.0M0.00-90.0M0.00
 
 
 
Decrease In Investments-10.0M1.5M140.0M25.0M
 
 
 
 
 
Capital Expenditures-44.0K0.000.000.00
 
 
Net Assets From Acquisitions -63.5M-3.4M0.000.00
 
 
 
Net Cash Flow Investing61.9M-1.9M50.0M25.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-10.0M-14.0M0.00-301.0K
 
 
 
 
Net Proceeds Stock Sale49.0K0.0047.0K391.0K
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-9.9M-14.0M47.0K90.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-189.0K-14.0K44.0K105.0K
 
 
 
 
 
 
Net Change In Cash18.3M-65.8M10.0M8.8M